Analytical challenges and solutions in doping control: a perspective from the Swedish Doping Control Laboratory.

Abstract

BioanalysisVol. 8, No. 8 CommentaryAnalytical challenges and solutions in doping control: a perspective from the Swedish Doping Control LaboratoryMagnus EricssonMagnus Ericsson*Author for correspondence: E-mail Address: dopinglab@karolinska.se Doping Control Laboratory, Clinical Pharmacology, Karolinska University Hospital, Stockholm, SE 141 86, SwedenSearch for more papers by this authorPublished Online:23 Mar 2016https://doi.org/10.4155/bio-2016-0037AboutSectionsView ArticleView Full TextPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareShare onFacebookTwitterLinkedInReddit View articleKeywords: GC–MS/MSLC-HRMSOlympic GamesReferences1 World Anti-Doping Agency. The Prohibited List 2016. www.wada-ama.org.Google Scholar2 World Anti-Doping Agency. International Standard for Laboratories (ISL). www.wada-ama.org.Google Scholar3 Badoud F, Grataa E, Perrenoud L et al. Fast analysis of doping agents in urine by ultra-high-pressure liquid chromatography–quadrupole time-of-flight mass spectrometry I. Screening analysis. J. Chromatogr. A 1216, 4423–4433 (2009).Crossref, Medline, CAS, Google Scholar4 Girón A J, Deventer K, Roels K, Van Eenoo P. Development and validation of an open screening method for diuretics, stimulants and selected compounds in human urine by UHPLC–HRMS for doping control. Anal. Chim. Acta 721, 137–146 (2012).Crossref, Medline, Google Scholar5 World Anti-Doping Agency. The Technical document TD2016EAAS. www.wada-ama.org.Google Scholar6 Thörngren JO, Östervall F, Garle M. A high-throughput multicomponent screening method for diuretics, masking agents, central nervous system (CNS) stimulants and opiates in human urine by UPLC–MS/MS. J. Mass Spectrom. 43, 980–992 (2008).Crossref, Medline, Google Scholar7 World Anti-Doping Agency. The Technical document TD2015MRPL. www.wada-ama.org.Google Scholar8 Sottas PE, Saugy M, Saudan C. Endogenous steroid profiling in the athlete biological passport. Endocrinol. Metab. Clin. North Am. 39, 59 (2011).Crossref, Google Scholar9 Boscha J, Such-Sanmartína G, Seguraa J, Gutiérrez-Gallego B R. Tracking growth hormone abuse in sport: performance of marker proteins in a controlled setting. Anal. Chim. Acta 745, 118–123 (2012).Crossref, Medline, Google Scholar10 Van Renterghem P, Van Eenoo P, Sottas PE, Saugy M, Delbeke F. A pilot study on subject-based comprehensive steroid profiling: novel biomarkers to detect testosterone misuse in sports. Clin. Endocrinol. (Oxf.) 75(1), 134–140 (2011).Crossref, Medline, CAS, Google Scholar11 Schänzer W, Guddat S, Thomas A, Opfermann G, Geyer H, Thevis M. Expanding analytical possibilities concerning the detection of stanozolol misuse by means of high resolution/high accuracy mass spectrometric detection of stanozolol glucuronides in human sports drug testing. Drug Test. Anal. 5, 11–12 (2013).Crossref, Google Scholar12 Sobolevsky T, Rodchenkov G. Detection and mass spectrometric characterization of novel long-term dehydrochloromethyltestosterone metabolites in human urine. J. Steroid Biochem. Mol. Biol. 128(3–5), 121–127 (2012).Crossref, Medline, CAS, Google Scholar13 Buisson C, Marchand A, Bailloux I, Lahaussois A, Martin L, Molina A. Detection by LC–MS/MS of HIF stabilizer FG-4592 used as a new doping agent: Investigation on a positive case. J. Pharm. Biomed. Anal. 121, 181–187 (2016).Crossref, Medline, CAS, Google Scholar14 Leuenberger N, Barras L, Nicoli R et al. Hepcidin as a new biomarker for detecting autologous blood transfusion. Am. J. Hematol. doi: 10.1002/ajh.24313 (2016) (Epub ahead of print).Crossref, Medline, Google Scholar15 Malm C, Frangsmyr L, Holmberg S. Detection of autologous blood transfusion by proteomics: screening to find unique biomarkers. www.wada-ama.org/en/resources/science-medicine/detection-of-autologous-blood-transfusion-by-proteomicsscreening-to-find.Google ScholarFiguresReferencesRelatedDetailsCited ByCubosomic Supramolecular Solvents: Synthesis, Characterization, and Potential for High-Throughput Multiclass Testing of Banned Substances in Urine22 February 2022 | Analytical Chemistry, Vol. 94, No. 9Interest of HRMS systems in analytical toxicology: Focus on doping productsToxicologie Analytique et Clinique, Vol. 8A comprehensive study on the performance of different retention mechanisms in sport drug testing by liquid chromatography tandem mass spectrometryJournal of Chromatography B, Vol. 1178Supramolecular solvents in microextraction techniquesTwenty years of supramolecular solvents in sample preparation for chromatography: achievements and challenges ahead23 March 2020 | Analytical and Bioanalytical Chemistry, Vol. 412, No. 24Development and validation of a UHPLC-HRMS method for the simultaneous determination of the endogenous anabolic androgenic steroids in human serumJournal of Chromatography A, Vol. 1613Comprehensive analysis by liquid chromatography Q-Orbitrap mass spectrometry: Fast screening of peptides and organic molecules18 April 2018 | Journal of Mass Spectrometry, Vol. 53, No. 6 Vol. 8, No. 8 Follow us on social media for the latest updates Metrics Downloaded 162 times History Published online 23 March 2016 Published in print April 2016 Information© Future Science LtdKeywordsGC–MS/MSLC-HRMSOlympic GamesFinancial & competing interests disclosureThe author has no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.No writing assistance was utilized in the production of this manuscript.PDF download